2026-01-24 - Analysis Report
**Company Overview:** Align Technology is a medical device company that develops and sells dental and orthodontic products, mainly Invisalign, a clear aligner system for teeth straightening.

**Return Rate Comparison:**

* Cumulative return of review stock: -13.89%
* Cumulative return of comparison stock (S&P 500, VOO): 126.41%
* Divergence: -140.30 (current), -245.70 (max), -161.40 (min), 5.20% (relative divergence)

The cumulative return of Align Technology is significantly lower than that of the S&P 500, indicating a large divergence. However, the relative divergence of 5.20% suggests that the stock's performance is at the lower end of its historical range.

**Historical Analysis:**

| Year | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------|------|------|-------|------|-------|
| 2016-2018 | 64.0% | 49.0% | 52.0% | 1.5 | 15.2B |
| 2017-2019 | 80.0% | 50.6% | 54.0% | 1.6 | 20.2B |
| 2018-2020 | 82.0% | 56.1% | 58.0% | 1.5 | 38.7B |
| 2019-2021 | 171.0% | 52.7% | 106.0% | 1.5 | 47.6B |
| 2020-2022 | -67.0% | 73.6% | -74.0% | 1.5 | 15.3B |
| 2021-2023 | -191.0% | 73.6% | -212.0% | 1.7 | 19.9B |
| 2022-2024 | -171.0% | 65.4% | -200.0% | 1.7 | 15.1B |
| 2023-2025 | -63.0% | 59.4% | -138.0% | 1.5 | 11.3B |

The company has experienced significant growth in CAGR, but the MDD (Maximum Drawdown) has also been increasing, indicating a higher risk. Alpha and Beta values have been relatively stable.

**Recent Stock Price Fluctuations:**

* Close: $168.73
* Last-market: $168.73 (price), $168.92 (previous close), -$0.11 (change)
* 5-day SMA: $168.93
* 20-day SMA: $165.49
* 60-day SMA: $153.17

The stock price has been fluctuating around the 5-day SMA, but is below the 20-day and 60-day SMAs.

**RSI, PPO, and Delta_Previous_Relative_Divergence Analysis:**

* Market Risk Indicator (MRI): 0.70 (low to medium risk)
* RSI: 67.72 (above 50, indicating overbought)
* PPO: -0.33 (indicating a sell signal)
* Hybrid Signal: Buy (no cash allocation)
* Recent (20 days) relative divergence change: -0.10 (worsening)
* 7-day Rank change: 175 (rank up)
* 7-day Dynamic Expected Return change: 864.90 (improving)

The RSI is above 50, indicating overbought conditions, while the PPO suggests a sell signal. The MRI is in the low to medium risk range.

**Expected Return:** -793.60% (expected excess return compared to S&P 500 if invested long-term)

**Recent News & Significant Events:**

* [2026-01-22] Assessing Align Technology (ALGN) Valuation After Recent Share Price Momentum And Mixed Signals - Yahoo Finance
* [2026-01-22] Align Expands Invisalign To Thailand As Analysts Reassess ALGN Outlook
* [2026-01-19] Align Technology Q4 Preview: Even After A Big Drop In Price, Itâ€™s Too Expensive (ALGN)
* [2026-01-20] Mizuho Maintains "Outperform" Rating for ALGN, Raises Price Target
* [2026-01-21] Align Tech (ALGN) Receives a Hold from UBS
* [2025-10-30] Why Align Technology Stock Popped Today

**Analyst Opinions:**

* Analyst Consensus:
  - Key: Buy
  - Mean (1=StrongBuy~5=Sell): 2.17 (~Buy)
  - Opinions: 15
  - Target Price (avg/high/low): 183.87 / 220.00 / 150.00

**Recent Earnings Analysis:**

| Date | EPS | Revenue |
|----|---:|---:|
| 2025-11-05 | 0.78 | 1.00 B$ |
| 2025-08-06 | 1.72 | 1.01 B$ |
| 2025-05-08 | 1.27 | 0.98 B$ |
| 2024-11-05 | 1.55 | 0.98 B$ |

The company has reported relatively stable EPS and revenue growth.

**Financial Information - Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $1.00B | 64.20% |
| 2025-06-30 | $1.01B | 69.94% |
| 2025-03-31 | $0.98B | 69.45% |
| 2024-12-31 | $1.00B | 70.03% |
| 2024-09-30 | $0.98B | 69.72% |

The company has experienced stable revenue growth and profit margin.

**Financial Information - Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $3.96B | 1.43% |
| 2025-06-30 | $3.91B | 3.18% |
| 2025-03-31 | $3.79B | 2.46% |
| 2024-12-31 | $3.85B | 2.69% |
| 2024-09-30 | $3.94B | 2.94% |

The company's equity has been increasing, while the ROE (Return on Equity) has been relatively stable.

**Comprehensive Analysis (Summary):**

Align Technology has experienced a significant divergence from the S&P 500, with a cumulative return of -13.89% compared to 126.41% for the S&P 500. The stock price has been fluctuating around the 5-day SMA, but is below the 20-day and 60-day SMAs. The RSI is above 50, indicating overbought conditions, while the PPO suggests a sell signal. The MRI is in the low to medium risk range. The company has reported stable EPS and revenue growth, while the profit margin and ROE have been relatively stable. The analyst consensus is Buy, with a target price of $183.87.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.